Equities

TransGenic Group Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
2342:TYO

TransGenic Group Inc

Actions
IndustrialsIndustrial Support Services
  • Price (JPY)296.00
  • Today's Change-7.00 / -2.31%
  • Shares traded360.50k
  • 1 Year change+60.00%
  • Beta0.6191
Data delayed at least 15 minutes, as of Feb 13 2026 06:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

TransGenic Group Inc, formerly Trans Genic Inc is a Japan-based company mainly engaged in the drug discovery support business and the investment and consulting business. The Company operates through two business segments. The Drug Discovery Support Business segment provides seamless services that can handle all stages of drug discovery, from the initial stages of drug discovery, such as basic research and drug discovery research, to non-clinical and clinical trials. Its main services include contract production of genetically modified mice, contract production of antibodies and glycosylation analysis and synthesis. The Investment and Consulting Business segment promotes new businesses through mergers and acquisitions (M&A) and provides advice and support services related to business succession and business revitalization in a wide range of fields.

  • Revenue in JPY (TTM)12.89bn
  • Net income in JPY-769.96m
  • Incorporated1998
  • Employees241.00
  • Location
    TransGenic Group IncibbFUKUOKA Bldg.2-3-36, Tenjin, Chuo-kuFUKUOKA-SHI 810-0001JapanJPN
  • Phone+81 922888470
  • Fax+81 922888473
  • Websitehttps://transgenic-group.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
RAVIPA Ltd1.81bn250.23m1.06bn14.00----3.890.5877126.38126.38915.05213.882.074.2315.98--28.64--48.57--81.95--13.81--1.9166.110.4788--10.57--153.87------
Creema Ltd2.49bn38.98m1.66bn79.0042.681.5420.730.66885.795.79369.34160.700.7194--4.6531,507,770.001.131.063.012.8779.6485.351.571.54--20.110.29550.00-0.07810.5630.17---53.46--
Yumemitsuketai Co Ltd308.06m134.97m2.15bn10.0015.440.784322.726.9913.3413.3430.45262.660.09040.176716.9630,805,900.003.963.164.624.0359.6050.3843.8122.900.114--0.19970.00-53.58-13.45-35.50------
P-Ban.Com Corp2.27bn132.66m2.55bn40.0018.151.6916.371.1328.2228.22481.87302.231.3262.627.8856,644,920.007.747.369.559.1337.7734.035.865.714.27122.060.016634.118.180.43920.640.1199-13.3214.87
Micreed Co Ltd7.42bn286.00m3.16bn28.0011.041.979.120.425343.1943.191,120.39242.662.8215.547.66264,928,600.0010.866.0218.349.3434.2134.113.862.121.87--0.0020.5314.1510.7216.2219.7035.8946.52
Tea Life Co Ltd11.22bn336.00m4.94bn144.0014.670.77529.890.440178.7478.742,628.111,490.041.277.5512.0577,881,940.003.826.014.457.1936.4437.853.004.093.36--0.123140.06-11.531.6912.23-3.18-46.635.92
TransGenic Group Inc12.89bn-769.96m5.03bn241.00--0.9973--0.3903-46.24-46.24774.19296.811.244.038.1353,496,540.00-7.541.81-12.152.4817.8221.30-6.081.431.11--0.365730.95-0.59873.32-26,774.20---7.33--
Kuradashi Co Ltd3.20bn40.69m5.16bn39.00114.633.3833.821.613.713.71283.83125.811.1616.7516.0182,176,740.001.47--2.09--47.57--1.27--1.6819.850.4997--7.47---348.89------
J Frontier Co Ltd21.34bn-111.68m7.12bn202.00--5.0711.650.3337-20.05-20.054,110.19263.232.256.1314.90105,624,200.00-1.13-9.12-2.78-17.9542.1648.48-0.5043-3.850.7212--0.707--21.3924.79104.20-1.9064.48--
Crooz Inc11.71bn-370.49m7.41bn712.00--0.6155--0.633-38.71-38.711,222.99929.280.377614.064.9716,444,680.00-1.201.75-1.482.2750.5236.58-3.182.471.88-12.700.6860.00-0.5516-16.03-152.61---6.78--
Hamee Corp23.45bn912.13m7.85bn489.008.430.69294.360.334957.0957.091,467.97694.161.292.178.6047,955,960.005.0111.417.9015.5359.4160.913.898.271.3811.130.316823.9630.0015.1213.943.633.8226.30
Felissimo Corp29.52bn577.00m8.26bn419.0010.690.31655.710.2881.0181.014,144.562,736.081.022.799.3570,453,460.001.991.832.632.5854.4753.591.951.831.94--0.0018.35-0.53370.5819115.85-17.92-11.5024.57
Data as of Feb 13 2026. Currency figures normalised to TransGenic Group Inc's reporting currency: Japanese Yen JPY

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Yuki Management & Research Co. Ltd.as of 31 Jan 20220.000.00%
Data from 31 Jan 2022 - 31 Jan 2022Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.